Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
Resource Type
Article
Authors
Liu, Xinxue ; Munro, Alasdair P S ; Feng, Shuo ; Janani, Leila ; Aley, Parvinder K ; Babbage, Gavin ; Baxter, David ; Bula, Marcin ; Cathie, Katrina ; Chatterjee, Krishna ; Dejnirattisai, Wanwisa ; Dodd, Kate ; Enever, Yvanne ; Qureshi, Ehsaan ; Goodman, Anna L. ; Green, Christopher A ; Harndahl, Linda ; Haughney, John ; Hicks, Alexander ; van der Klaauw, Agatha A. ; Kwok, Jonathan ; Libri, Vincenzo ; Llewelyn, Martin J ; McGregor, Alastair C ; Minassian, Angela M. ; Moore, Patrick ; Mughal, Mehmood ; Mujadidi, Yama F ; Holliday, Kyra ; Osanlou, Orod ; Osanlou, Rostam ; Owens, Daniel R ; Pacurar, Mihaela ; Palfreeman, Adrian ; Pan, Daniel ; Rampling, Tommy ; Regan, Karen ; Saich, Stephen ; Serafimova, Teona ; Saralaya, Dinesh ; Screaton, Gavin R ; Sharma, Sunil ; Sheridan, Ray ; Sturdy, Ann ; Supasa, Piyada ; Thomson, Emma C ; Todd, Shirley ; Twelves, Chris ; Read, Robert C. ; Charlton, Sue ; Hallis, Bassam ; Ramsay, Mary ; Andrews, Nick ; Lambe, Teresa ; Nguyen-Van-Tam, Jonathan S ; Cornelius, Victoria ; Snape, Matthew D ; Faust, Saul N
Source
In Journal of Infection June 2022 84(6):795-813
Subject
Language
ISSN
0163-4453